Correlation Between Benitec Biopharma and Lixte Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Benitec Biopharma and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Benitec Biopharma and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Benitec Biopharma Ltd and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Benitec Biopharma and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Benitec Biopharma with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Benitec Biopharma and Lixte Biotechnology.

Diversification Opportunities for Benitec Biopharma and Lixte Biotechnology

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Benitec and Lixte is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Benitec Biopharma Ltd and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Benitec Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Benitec Biopharma Ltd are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Benitec Biopharma i.e., Benitec Biopharma and Lixte Biotechnology go up and down completely randomly.

Pair Corralation between Benitec Biopharma and Lixte Biotechnology

Given the investment horizon of 90 days Benitec Biopharma Ltd is expected to under-perform the Lixte Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Benitec Biopharma Ltd is 1.88 times less risky than Lixte Biotechnology. The stock trades about -0.07 of its potential returns per unit of risk. The Lixte Biotechnology Holdings is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  195.00  in Lixte Biotechnology Holdings on September 3, 2024 and sell it today you would earn a total of  28.00  from holding Lixte Biotechnology Holdings or generate 14.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Benitec Biopharma Ltd  vs.  Lixte Biotechnology Holdings

 Performance 
       Timeline  
Benitec Biopharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Benitec Biopharma Ltd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Benitec Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Lixte Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Benitec Biopharma and Lixte Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Benitec Biopharma and Lixte Biotechnology

The main advantage of trading using opposite Benitec Biopharma and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Benitec Biopharma position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.
The idea behind Benitec Biopharma Ltd and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format